Publicaciones en colaboración con investigadores/as de Clínica Universitaria de Navarra (163)

2024

  1. Estudio de estabilidad fisicoquímica y microbiológica de dos nuevos colirios de metilprednisolona sin conservantes

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 48, Núm. 4, pp. 145-152

  2. Physicochemical and microbiological stability study of two new preservative-free methylprednisolone eye drops

    Farmacia Hospitalaria

  3. Rna-loaded nanoparticles for the treatment of hematological cancers

    Advanced Drug Delivery Reviews, Vol. 214

  4. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut

2023

  1. A pharmacometrics model to define docetaxel target in early breast cancer

    British Journal of Clinical Pharmacology, Vol. 89, Núm. 2, pp. 727-736

2022

  1. Data on the effect of early treatment with ivermectin on viral load, symptoms and humoral response in patients with mild COVID-19.

    CORA.Repositori de Dades de Recerca

  2. Trastuzumab and thyroid dysfunction: An association to be aware of

    Journal of Cancer Research and Therapeutics, Vol. 18, Núm. 4, pp. 1183-1185

2021

  1. Author Correction: Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation (Scientific Reports, (2019), 9, 1, (14172), 10.1038/s41598-019-50627-w)

    Scientific Reports

  2. Farmacocinética y farmacogenética en la optimización de los tratamientos en psiquiatría: Revisión sistemática

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 7, pp. 84-93

  3. In vivo SPECT-CT imaging and characterization of technetium-99m-labeled bevacizumab-loaded human serum albumin pegylated nanoparticles

    Journal of Drug Delivery Science and Technology, Vol. 64

  4. The importance of being able to compare: Methodologies that result in the best decisions

    Farmacia Hospitalaria

  5. Transfer of SCN1A to the brain of adolescent mouse model of Dravet syndrome improves epileptic, motor, and behavioral manifestations

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 585-602

2020

  1. Bioequivalence Evaluation of Three Pediatric Oral Formulations of Bilastine in Healthy Subjects: Results from a Randomized, Open Label, Crossover Study

    European Journal of Drug Metabolism and Pharmacokinetics, Vol. 45, Núm. 2, pp. 265-272

  2. Cost-minimization analysis of individually tailored or fixed-scheduled rituximab maintenance therapy for antineutrophil-cytoplasm antibody associated vasculitides

    Farmacia Hospitalaria, Vol. 44, Núm. 2, pp. 46-50

  3. Evaluar medicamentos también es una actividad clínica

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 45, Núm. 1, pp. 45-47

  4. Predicting circulating biomarker response and its impact on the survival of advanced melanoma patients treated with adjuvant therapy

    Scientific Reports, Vol. 10, Núm. 1

  5. interprofessional education: A proposal from the University of Navarra

    Educacion Medica

2019

  1. Assessing the impact of the addition of dendritic cell vaccination to neoadjuvant chemotherapy in breast cancer patients: A model-based characterization approach

    British Journal of Clinical Pharmacology, Vol. 85, Núm. 8, pp. 1670-1683

  2. Efficacy and safety of long-term use of tedizolid after liver transplantation in an adolescent with pulmonary tuberculosis

    Journal of Antimicrobial Chemotherapy

  3. Epilepsy and neuropsychiatric comorbidities in mice carrying a recurrent Dravet syndrome SCN1A missense mutation

    Scientific Reports, Vol. 9, Núm. 1